Ning Deng

Company: BridGene Biosciences Inc.

Job title: Director - IMTAC Discovery

Seminars:

Covalent Drug Discovery by Chemoproteomics: Deconvolution of Phenotypic Screening Hits Through IMTAC Proteome-Wide, Live-Cell Screening 11:30 am

Discussing the advantages of IMTAC proteome-wide, live-cell screening to further drug discovery efforts Identification of novel targets with the potential to overcome acquired chemotherapy resistance in high-grade serous ovarian cancerRead more

day: Conference Day 1